Ertapenem (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ertapenem" in English language version.

refsWebsite

Global rank English rank

15nih.gov

4^th place

8doi.org

2^nd place

5semanticscholar.org

11^th place

8^th place

3europa.eu

68^th place

117^th place

2drugs.com

399^th place

333^rd place

2tga.gov.au

3,984^th place

2,622^nd place

1medicines.org.uk

3,823^rd place

2,387^th place

1fda.gov

447^th place

338^th place

1amsterdamumc.org

low place

1mediq.ch

low place

1books.google.com

3^rd place

1handle.net

102^nd place

76^th place

amsterdamumc.org

"Antibiotic Ertapenem is alternative drug in treatment of gonorrhea". Amsterdam UMC. 20 January 2022. Retrieved 8 July 2022.

books.google.com

Zaccara G (31 December 2012). "Antiepileptic drugs". In Aronson JK (ed.). Side Effects of Drugs Annual 34: A worldwide yearly survey of new data in adverse drug reactions. Newnes. p. 121. ISBN 978-0-444-59503-4.

doi.org

Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (November 2011). "Carbapenems: past, present, and future". Antimicrobial Agents and Chemotherapy. 55 (11): 4943–4960. doi:10.1128/AAC.00296-11. PMC 3195018. PMID 21859938.
de Vries HJ, de Laat M, Jongen VW, Heijman T, Wind CM, Boyd A, et al. (May 2022). "Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial". The Lancet. Infectious Diseases. 22 (5): 706–717. doi:10.1016/S1473-3099(21)00625-3. PMID 35065063. S2CID 246129045.
Wu CC, Pai TY, Hsiao FY, Shen LJ, Wu FL (October 2016). "The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations". Therapeutic Drug Monitoring. 38 (5): 587–592. doi:10.1097/FTD.0000000000000316. PMID 27322166. S2CID 25445129.
Mancl EE, Gidal BE (December 2009). "The effect of carbapenem antibiotics on plasma concentrations of valproic acid". The Annals of Pharmacotherapy. 43 (12): 2082–2087. doi:10.1345/aph.1M296. PMID 19934386. S2CID 207263641.
Liao FF, Huang YB, Chen CY (August 2010). "Decrease in serum valproic acid levels during treatment with ertapenem". American Journal of Health-System Pharmacy. 67 (15): 1260–1264. doi:10.2146/ajhp090069. PMID 20651316.
Cushnie TP, O'Driscoll NH, Lamb AJ (December 2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMC 11108400. PMID 27392605. S2CID 2065821.
Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA (September 2015). "Systemic antibiotics for treating diabetic foot infections". The Cochrane Database of Systematic Reviews. 2015 (9): CD009061. doi:10.1002/14651858.CD009061.pub2. PMC 8504988. PMID 26337865.
Tchero H, Kangambega P, Noubou L, Becsangele B, Fluieraru S, Teot L (September 2018). "Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials". Wound Repair and Regeneration. 26 (5): 381–391. doi:10.1111/wrr.12649. PMID 30099812. S2CID 51966152.

drugs.com

"Ertapenem (Invanz) Use During Pregnancy". Drugs.com. 24 January 2020. Retrieved 29 July 2020.
"Ertapenem Sodium Monograph for Professionals". Drugs.com. The American Society of Health-System Pharmacists. 29 June 2020. Retrieved 29 July 2020.

europa.eu

ema.europa.eu

"Invanz EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 29 July 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Invanz: EPAR – Product Information" (PDF). European Medicines Agency. 19 November 2019.
"Invanz: EPAR – Summary for the public" (PDF). European Medicines Agency. 2 December 2016.

fda.gov

accessdata.fda.gov

"Drug Approval Package: Invanz I.V. or I.M. (Ertapenem Sodium) NDA #21-337". U.S. Food and Drug Administration (FDA). 20 November 2001. Retrieved 29 July 2020.

handle.net

hdl.handle.net

Cushnie TP, O'Driscoll NH, Lamb AJ (December 2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMC 11108400. PMID 27392605. S2CID 2065821.

medicines.org.uk

"Invanz 1g powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC)". (emc). Retrieved 29 July 2020.

mediq.ch

"Ertapenem". mediQ. Retrieved 29 July 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (November 2011). "Carbapenems: past, present, and future". Antimicrobial Agents and Chemotherapy. 55 (11): 4943–4960. doi:10.1128/AAC.00296-11. PMC 3195018. PMID 21859938.
de Vries HJ, de Laat M, Jongen VW, Heijman T, Wind CM, Boyd A, et al. (May 2022). "Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial". The Lancet. Infectious Diseases. 22 (5): 706–717. doi:10.1016/S1473-3099(21)00625-3. PMID 35065063. S2CID 246129045.
Wu CC, Pai TY, Hsiao FY, Shen LJ, Wu FL (October 2016). "The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations". Therapeutic Drug Monitoring. 38 (5): 587–592. doi:10.1097/FTD.0000000000000316. PMID 27322166. S2CID 25445129.
Mancl EE, Gidal BE (December 2009). "The effect of carbapenem antibiotics on plasma concentrations of valproic acid". The Annals of Pharmacotherapy. 43 (12): 2082–2087. doi:10.1345/aph.1M296. PMID 19934386. S2CID 207263641.
Liao FF, Huang YB, Chen CY (August 2010). "Decrease in serum valproic acid levels during treatment with ertapenem". American Journal of Health-System Pharmacy. 67 (15): 1260–1264. doi:10.2146/ajhp090069. PMID 20651316.
Pandey N, Cascella M (June 2023). "Beta-Lactam Antibiotics". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 31424895.
Cushnie TP, O'Driscoll NH, Lamb AJ (December 2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMC 11108400. PMID 27392605. S2CID 2065821.
Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA (September 2015). "Systemic antibiotics for treating diabetic foot infections". The Cochrane Database of Systematic Reviews. 2015 (9): CD009061. doi:10.1002/14651858.CD009061.pub2. PMC 8504988. PMID 26337865.
Tchero H, Kangambega P, Noubou L, Becsangele B, Fluieraru S, Teot L (September 2018). "Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials". Wound Repair and Regeneration. 26 (5): 381–391. doi:10.1111/wrr.12649. PMID 30099812. S2CID 51966152.

ncbi.nlm.nih.gov

Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (November 2011). "Carbapenems: past, present, and future". Antimicrobial Agents and Chemotherapy. 55 (11): 4943–4960. doi:10.1128/AAC.00296-11. PMC 3195018. PMID 21859938.
Pandey N, Cascella M (June 2023). "Beta-Lactam Antibiotics". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID 31424895.
Cushnie TP, O'Driscoll NH, Lamb AJ (December 2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMC 11108400. PMID 27392605. S2CID 2065821.
Selva Olid A, Solà I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA (September 2015). "Systemic antibiotics for treating diabetic foot infections". The Cochrane Database of Systematic Reviews. 2015 (9): CD009061. doi:10.1002/14651858.CD009061.pub2. PMC 8504988. PMID 26337865.

dailymed.nlm.nih.gov

"Invanz- ertapenem sodium injection, powder, lyophilized, for solution". DailyMed. 13 February 2020. Retrieved 29 July 2020.

pubchem.ncbi.nlm.nih.gov

"Ertapenem Ring Open Impurity". PubChem. U.S. National Library of Medicine. CID 45105276. Retrieved 30 July 2020.

semanticscholar.org

api.semanticscholar.org

de Vries HJ, de Laat M, Jongen VW, Heijman T, Wind CM, Boyd A, et al. (May 2022). "Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial". The Lancet. Infectious Diseases. 22 (5): 706–717. doi:10.1016/S1473-3099(21)00625-3. PMID 35065063. S2CID 246129045.
Wu CC, Pai TY, Hsiao FY, Shen LJ, Wu FL (October 2016). "The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations". Therapeutic Drug Monitoring. 38 (5): 587–592. doi:10.1097/FTD.0000000000000316. PMID 27322166. S2CID 25445129.
Mancl EE, Gidal BE (December 2009). "The effect of carbapenem antibiotics on plasma concentrations of valproic acid". The Annals of Pharmacotherapy. 43 (12): 2082–2087. doi:10.1345/aph.1M296. PMID 19934386. S2CID 207263641.
Cushnie TP, O'Driscoll NH, Lamb AJ (December 2016). "Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action". Cellular and Molecular Life Sciences. 73 (23): 4471–4492. doi:10.1007/s00018-016-2302-2. hdl:10059/2129. PMC 11108400. PMID 27392605. S2CID 2065821.
Tchero H, Kangambega P, Noubou L, Becsangele B, Fluieraru S, Teot L (September 2018). "Antibiotic therapy of diabetic foot infections: A systematic review of randomized controlled trials". Wound Repair and Regeneration. 26 (5): 381–391. doi:10.1111/wrr.12649. PMID 30099812. S2CID 51966152.

tga.gov.au

"INVANZ ertapenem (as sodium) 1g powder for injection vial (81449)". Therapeutic Goods Administration (TGA). 12 August 2022. Retrieved 21 April 2023.

ebs.tga.gov.au

"TGA eBS - Product and Consumer Medicine Information Licence".